Loading clinical trials...

Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITING

Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups

Impact of Non-stenting Method with Mucosal Eversion on Biliary Complications Post-LDLT in a Mid-volume Center: a Propensity Score-Matching Analysis of Case-Control Study

NCT06767553•Chungnam National University Hospital

View on ClinicalTrials.gov

Summary

Despite technological advancements in living donor liver transplantation (LDLT), biliary complications (BC), including biliary anastomotic stricture (BAS) and bile leak (BL), remain unresolved issues that significantly affect patient outcomes. Biliary stenting has emerged as a potential method for reducing BC in LDLT procedures; however, their necessity remains debated. This study aimed to assess the necessity of biliary stenting by retrospectively comparing the bile duct complication rates in LDLT using duct-to-duct anastomosis with or without biliary stenting.

Eligibility

Age

19 - 80 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adults aged between 19 and 80 years at the time of liver transplantation.
•Patients who underwent liver transplantation surgery for liver disease performed by the Department of Surgery at Chungnam National University Hospital under the supervision of the principal investigator.
•Patients who signed the informed consent form before study registration (for future participants).

Exclusion Criteria

•Patients who have not signed the informed consent form or have insufficient understanding of the clinical trial protocol, making it difficult to accurately express their intention to participate.
•Patients deemed unsuitable for participation in this clinical study by the investigator.

Locations (1)

Chungnam National University Hospital

Daejeon, South Korea

Key Dates

Start Date

November 1, 2011

Primary Completion Date

October 31, 2024

Completion Date

November 30, 2027

Last Updated

January 10, 2025

Enrollment

160

ESTIMATED participants

Conditions

Liver FailureLiving Donor Liver TransplantationBiliary ComplicationsBiliary Stents

ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF

NCT07329036

Acute Liver Failure

View study

RECRUITINGNA

Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure

NCT06831643

Acute Liver Failure

View study

RECRUITING

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups

Inclusion Criteria

Exclusion Criteria

ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF

Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients

The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients